phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide has been researched along with myelin basic protein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eschenroeder, AC; Robinson, SE; Sanchez, ES; Sato-Bigbee, C; Vestal-Laborde, AA | 1 |
1 other study(ies) available for phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and myelin basic protein
| Article | Year |
|---|---|
Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.
Topics: Analgesics, Opioid; Animals; Animals, Newborn; Apoptosis; Brain; Buprenorphine; Dose-Response Relationship, Drug; Gene Expression Regulation; Methadone; Myelin Basic Protein; Nociceptin; Nociceptin Receptor; O Antigens; Oligodendroglia; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, mu; Somatostatin; Time Factors | 2012 |